| BioID | bio2940 |
| Name | ACRIVASTINE |
| ChEMBL ID | CHEMBL1224 |
| Molecular Formula | C22H24N2O2 |
| Molecular Weight | 348.45 |
| Molecular Weight (Monoisotopic) | 348.1838 |
| Type | Small molecule |
| Max Phase | Phase 4 |
| Target ID | Tar12 |
| Target Name | Toll-like receptor 9 (TLR9) |
| Synonyms | ACRIVASTINA|ACRIVASTINE|BENADRYL ALLGY RELIEF PLUS DECONGEST|BW 825C|BW-825C|SEMPREX |
| Smiles | Cc1ccc(/C(=C\CN2CCCC2)c2cccc(/C=C/C(=O)O)n2)cc1 |
| Inchi | InChI=1S/C22H24N2O2/c1-17-7-9-18(10-8-17)20(13-16-24-14-2-3-15-24)21-6-4-5-19(23-21)11-12-22(25)26/h4-13H,2-3,14-16H2,1H3,(H,25,26)/b12-11+,20-13+ |
| Inchi Key | PWACSDKDOHSSQD-IUTFFREVSA-N |
| Molecular Species | ZWITTERION |
| Targets | 73.0 |
| Bioactivities | 113.0 |
| Np Likeness Score | -0.49 |
| Records Key | ['acrivastine', 'acrivastine', 'acrivastine', 'ACRIVASTINE', 'Acrivastine', 'ACRIVASTINE', 'Acrivastine', 'SID144206566', 'Acrivastine', 'ACRIVASTINE', 'Acrivastine', 'ACRIVASTINE', 'acrivastine', 'Acrivastine', 'Acrivastine', 'ACRIVASTINE', 'COVC-0141980912', 'Acrivastine', 'acrivastine'] |
| Records Name | ['(E)-3-[6-((E)-3-Pyrrolidin-1-yl-1-p-tolyl-propenyl)-pyridin-2-yl]-acrylic acid', '3-{6-[1-(4-methylphenyl)-3-tetrahydro-1H-1-pyrrolyl-(E)-1-propenyl]-2-pyridyl}-(E)-2-propenoic acid', '(E)-3-[6-((E)-3-Pyrrolidin-1-yl-1-p-tolyl-propenyl)-pyridin-2-yl]-acrylic acid', 'ACRIVASTINE', 'Acrivastine', 'ACRIVASTINE', 'Acrivastine', 'SID144206566', 'Acrivastine', 'ACRIVASTINE', 'Acrivastine', 'ACRIVASTINE', 'acrivastine', 'Acrivastine', 'Acrivastine', 'ACRIVASTINE', 'ACRIVASTINE', 'Acrivastine', 'acrivastine'] |
| Withdrawn Flag | False |
| Orphan | 0 |